Premium
Healthcare-focused private equity firm Quadria Capital made its first exit from its India portfolio, following the acquisition of Strand Life Sciences Pvt. Ltd., by Reliance Industries Ltd. The exit comes just a little over three years after Quadria had invested in Strand Life Sciences--a clinical genomics and biotechnology research firm, in ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
